Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements
13. August 2024 16:05 ET
|
Alumis Inc.
– Initiated patient dosing in ESK-001 Phase 3 ONWARD clinical program in moderate-to-severe plaque psoriasis – – Initiated Phase 1 clinical trial for A-005 in healthy participants – – Completed IPO...
Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis
29. Juli 2024 08:00 ET
|
Alumis Inc.
Alumis announced that patient dosing has commenced in the ONWARD Phase 3 clinical program for ESK-001 for the treatment of psoriasis.
ONWARD erhält weitere FDA Breakthrough Device Designations für Blasenkontrolle, Linderung von Spastiken und Blutdruckregulation nach Rückenmarksverletzung
23. Februar 2023 01:30 ET
|
ONWARD Medical
EINDHOVEN, Niederlande, LAUSANNE, Schweiz und BOSTON, MA USA, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Das Medizintechnikunternehmen ONWARD Medical N.V. (Euronext: ONWD), das innovative Therapien zur...
ONWARD reçoit de nouvelles désignations de dispositifs révolutionnaires de la FDA pour le contrôle de la vessie, le soulagement de la spasticité et la régulation de la pression artérielle après une lésion de la moelle épinière
23. Februar 2023 01:30 ET
|
ONWARD Medical
EINDHOVEN, Pays-Bas, LAUSANNE, Suisse, et BOSTON, MA, Etats-Unis, 23 févr. 2023 (GLOBE NEWSWIRE) -- ONWARD Medical SA (Euronext : ONWD), société de technologie médicale créant des thérapies...
ONWARD ontvangt nieuwe FDA Breakthrough Device Designations voor blaascontrole, vermindering van spasticiteit en bloeddrukregeling bij dwarslaesiepatiënten
23. Februar 2023 01:30 ET
|
ONWARD Medical
EINDHOVEN, Nederland, LAUSANNE, Zwitserland & BOSTON, MA, VS, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), ONWARD Medical N.V. (Euronext: ONWD), het medische...
ONWARD Receives New FDA Breakthrough Device Designations for Bladder Control, Alleviation of Spasticity, and Blood Pressure Regulation after Spinal Cord Injury
23. Februar 2023 01:30 ET
|
ONWARD Medical
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative...